Abstract
In this study, we report the molecular structure of the breakpoint region in a new chromosomal translocation, t(2;7)(p24.3;p14.2), in a case of acute myeloid leukemia transformed from myelodysplastic syndrome (MDS). An extensive fluorescence in situ hybridization (FISH) analysis showed that NAG (2p24.3) and ELMO1 (7p14.2) were involved at the breakpoints of t(2;7)(p24.3;p14.2). Furthermore, we detected a novel chimeric transcript consisting of NAG and ELMO1. Interestingly, this transcript encoded a truncated molecular form of 3′ELMO1 as the result of a frameshift caused by the chromosomal translocation. Although this study does not provide direct evidence that a defect in NAG-ELMO1 plays a role in the pathogenesis or the leukemic change in MDS, it does suggest that defects in NAG-ELMO1 potentially contributed to the leukemic progression in this case.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Raskind, W. H., Tirumali, N., Jacobson, R., Singer, J. & Fialkow, P. J. Evidence for a multistep pathogenesis of myelodysplastic syndrome. Blood 63, 1318–1323 (1984).
Janssen, J. W. G., Buschle, M., Layton, M., Drexler, H. G., Lyons, J. & Van Den Berghe, H. et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 73, 248–254 (1989).
Fenaux, P. Myelodysplastic syndromes. Hematol. Cell Ther. 38, 363–380 (1996).
Van Lom, K., Hagemeijer, A., Vandekerkhove, F., Smit, E. M. E. & Löwenberg, B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukemia. Br. J. Haematol. 93, 594–600 (1996).
Mhawech, P. & Saleem, A. Myelodysplastic syndrome: review of the cytogenetic and molecular data. Crit. Rev. Oncol. Hematol. 40, 229–238 (2001).
Hirai, H. Molecular mechanism of myelodysplastic syndrome. Jap. J. Clin. Oncol. 33, 153–160 (2003).
Fenaux, P. Chromosome and molecular abnormalities in myelodysplastic syndrome. Int. J. Hematol. 73, 429–437 (2001).
Chen, Z., Morgan, R., Baer, M. R., Ligorsky, R. & Sandberg, A. A. Translocation (3;21) characterizes crises in myeloid stem cell disorders. Cancer Genet. Cytognet. 57, 153–159 (1991).
Golub, T. R., Barker, G. F., Lovett, M. & Gilliland, D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosome translocation. Cell 77, 307–316 (1994).
Taki, T., Sako, M., Tsuchida, M. & Hayashi, Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89, 3945–3950 (1997).
Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H. et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13, 504–510 (1994).
Wimmer, K., Zhu, X. X., Lamb, B. J., Kuick, R., Ambros, P. F., Kovar, H. et al. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 18, 233–238 (1999).
Scott, D. K., Board, J. R., Lu, X., Pearson, A. D. J., Kenyon, R. M. & Lunec, J. The neuroblastoma amplified gene, NAG: genomic structure and characterization of the 7.3 kb transcript predominantly expressed in neuroblastoma. Gene 307, 1–11 (2003).
Gumienny, T. L., Brugnera, E., Tosello-Trampont, A. C., Kinchen, J. M., Haney, L. B., Nishiwaki, K. et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107, 27–41 (2001).
Inazawa, J., Ariyama, T. & Abe, T. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescent in situ hybridization. Jpn. J. Cancer Res. 83, 1248–1252 (1992).
Borrow, J., Shearman, A. M., Stanton, Jr. V. P., Becher, R., Collins, T., Williams, A. J. et al. The (7;11)(p15;p15) translocation in acute myeloid leukemia fuses the genes for nucleoporin NUP98 and class homeoprotein HOXA9. Nat. Genet. 12, 159–167 (1996).
Nakamura, T., Largaespada, D. A., Lee, M. P., Johnson, L. A., Ohyashiki, K., Toyama, K. et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12, 154–158 (1996).
Imagama, S., Abe, A., Suzuki, M., Hayakawa, F., Katsumi, A., Emi, N. et al. LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). Eur. J. Haematol. 79, 25–31 (2007).
Lin, Y. W., Slape, C., Zhang, Z. & Aplan, P. D. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 106, 287–295 (2005).
Harada, H. & Harada, Y. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome. Crit. Rev. Eukaryot. Gene Expr. 15, 183–196 (2005).
Rosenfeld, C. & List, A. A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14, 2–8 (2000).
Paulsson, K., Heidenblad, M., Strömbeck, B., Staaf, J., Jönsson, G., Borg, A. et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 20, 840–846 (2006).
Gasparini, P., Sozzi, G. & Pierotti, M. A. The role of chromosomal alterations in human cancer development. J. Cell. Biochem. 102, 320–331 (2007).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Fujita, K., Sanada, M., Harada, H. et al. Molecular cloning of t(2;7)(p24.3;p14.2), a novel chromosomal translocation in myelodysplastic syndrome-derived acute myeloid leukemia. J Hum Genet 54, 355–359 (2009). https://doi.org/10.1038/jhg.2009.40
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2009.40
Keywords
This article is cited by
-
Role of ELMO1 in inflammation and cancer—clinical implications
Cellular Oncology (2022)
-
PAN3–PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia
Experimental Hematology & Oncology (2018)
-
DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung
Oncogene (2010)
